NDST3
Basic information
Region (hg38): 4:118033618-118258634
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NDST3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 31 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 0 | 0 |
Variants in NDST3
This is a list of pathogenic ClinVar variants found in the NDST3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-118053938-C-G | not specified | Uncertain significance (Sep 25, 2023) | ||
4-118053947-A-G | not specified | Uncertain significance (Jan 06, 2023) | ||
4-118053981-T-G | not specified | Uncertain significance (Jan 08, 2024) | ||
4-118053984-G-T | not specified | Uncertain significance (Jun 12, 2023) | ||
4-118054074-T-C | not specified | Uncertain significance (Nov 10, 2024) | ||
4-118054354-C-A | not specified | Uncertain significance (Feb 27, 2023) | ||
4-118054431-G-A | not specified | Uncertain significance (May 20, 2024) | ||
4-118054461-T-C | not specified | Uncertain significance (Apr 08, 2022) | ||
4-118054470-A-C | not specified | Uncertain significance (Mar 07, 2023) | ||
4-118054567-C-A | not specified | Uncertain significance (Nov 28, 2024) | ||
4-118054661-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
4-118054791-G-C | not specified | Uncertain significance (Nov 17, 2023) | ||
4-118054794-A-G | not specified | Uncertain significance (Jun 27, 2022) | ||
4-118054798-G-T | not specified | Uncertain significance (Jun 07, 2024) | ||
4-118054829-G-A | not specified | Uncertain significance (Nov 14, 2024) | ||
4-118054850-G-T | not specified | Uncertain significance (Jun 02, 2023) | ||
4-118105093-T-C | not specified | Uncertain significance (Apr 26, 2023) | ||
4-118114853-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
4-118114911-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
4-118138060-G-A | not specified | Uncertain significance (Mar 11, 2022) | ||
4-118138192-C-G | not specified | Uncertain significance (Apr 21, 2022) | ||
4-118138210-C-T | not specified | Uncertain significance (Mar 13, 2023) | ||
4-118138219-T-G | not specified | Uncertain significance (Oct 01, 2024) | ||
4-118138220-T-G | not specified | Uncertain significance (Oct 01, 2024) | ||
4-118138221-T-G | not specified | Uncertain significance (Oct 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NDST3 | protein_coding | protein_coding | ENST00000296499 | 13 | 225031 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000107 | 1.00 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.59 | 300 | 456 | 0.659 | 0.0000222 | 5776 |
Missense in Polyphen | 98 | 185.81 | 0.52742 | 2452 | ||
Synonymous | 0.151 | 162 | 164 | 0.985 | 0.00000837 | 1624 |
Loss of Function | 3.67 | 16 | 41.5 | 0.386 | 0.00000213 | 503 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000219 | 0.000214 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000187 | 0.000185 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Essential bifunctional enzyme that catalyzes both the N- deacetylation and the N-sulfation of glucosamine (GlcNAc) of the glycosaminoglycan in heparan sulfate. Modifies the GlcNAc-GlcA disaccharide repeating sugar backbone to make N-sulfated heparosan, a prerequisite substrate for later modifications in heparin biosynthesis. Has high deacetylase activity but low sulfotransferase activity. {ECO:0000269|PubMed:9915799}.;
- Pathway
- Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human);Metapathway biotransformation Phase I and II;Metabolism of carbohydrates;HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism;Glycosaminoglycan metabolism;heparan sulfate biosynthesis (late stages);heparan sulfate biosynthesis;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- loftool
- 0.567
- rvis_EVS
- -1
- rvis_percentile_EVS
- 8.47
Haploinsufficiency Scores
- pHI
- 0.353
- hipred
- Y
- hipred_score
- 0.640
- ghis
- 0.599
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.292
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ndst3
- Phenotype
- immune system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; vision/eye phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- heparan sulfate proteoglycan biosynthetic process;heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process;heparin biosynthetic process
- Cellular component
- Golgi membrane;cellular_component;Golgi apparatus;integral component of membrane
- Molecular function
- [heparan sulfate]-glucosamine N-sulfotransferase activity;deacetylase activity;heparan sulfate sulfotransferase activity;heparan sulfate N-acetylglucosaminyltransferase activity